Challenges in developing an ultra-sensitive bioanalytical method for ethinylestradiol in human plasma.

Area of Science:

• Pharmaceutical analysis
• Analytical chemistry
• Mass spectrometry

Background:

• Ethinylestradiol (EE) is a key component in oral contraceptives.
• Analyzing EE is complicated by coeluting endogenous steroids, impacting sample preparation and chromatographic separation.
• Modern mass spectrometry (MS) demands high sample and solvent purity, emphasizing robust sample preparation.

Purpose of the Study:

• To develop and validate a sensitive analytical method for ethinylestradiol (EE) determination.
• To address challenges in selective extraction and chromatographic separation of EE from complex matrices.
• To optimize sample preparation for enhanced MS detection.

Main Methods:

• Ultra-Performance Liquid Chromatography (UPLC) coupled with a sensitive triple quadrupole mass spectrometer (MS).
• A three-step sample preparation protocol was developed to mitigate matrix effects and improve analyte recovery.
• An unendcapped high-strength silica C(18) column was utilized for optimal chromatographic resolution.

Main Results:

• EE was well-resolved chromatographically, demonstrating effective separation from interfering substances.
• Low matrix effects were observed in plasma samples (average matrix factor 1.14, %CV 4.48).
• Linear standard curves (r(2) > 0.999) and high accuracy (96%) were achieved over three orders of magnitude, with a limit of detection (LOD) of 0.001 ng/ml.

Conclusions:

• The developed UPLC-MS method, combined with optimized sample preparation, enables sensitive and selective quantification of ethinylestradiol.
• This approach effectively overcomes common analytical challenges associated with EE analysis in complex biological matrices.
• The method's high sensitivity and accuracy support its application in pharmaceutical quality control and pharmacokinetic studies.